donepezil and bay 73-6691

donepezil has been researched along with bay 73-6691 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, JW; Chen, Y; Chen, YP; Geng, H; Li, Z; Luo, HB; Tian, YJ; Wang, Y; Wu, Y; Yu, YF; Zhang, C; Zhang, P; Zhang, T; Zhou, Q	1
Dorner-Ciossek, C; Giovannini, R; Kroker, KS; Marti, A; Rast, G; Rosenbrock, H	1

Other Studies

2 other study(ies) available for donepezil and bay 73-6691

Article	Year
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia. Journal of medicinal chemistry, 2019, 04-25, Volume: 62, Issue:8 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Binding Sites; Catalytic Domain; Dementia, Vascular; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Half-Life; Humans; Maze Learning; Mice; Molecular Docking Simulation; Phosphodiesterase Inhibitors; Protein Isoforms; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship	2019
Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Neuropharmacology, 2012, Volume: 62, Issue:5-6 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Excitatory Postsynaptic Potentials; Hippocampus; Indans; Long-Term Potentiation; Male; Phosphodiesterase Inhibitors; Piperidines; Pyrazoles; Pyrimidines; Rats; Rats, Wistar	2012

Article

Year

Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia.

Journal of medicinal chemistry, 2019, 04-25, Volume: 62, Issue:8

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Binding Sites; Catalytic Domain; Dementia, Vascular; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Half-Life; Humans; Maze Learning; Mice; Molecular Docking Simulation; Phosphodiesterase Inhibitors; Protein Isoforms; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2019

Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP.

Neuropharmacology, 2012, Volume: 62, Issue:5-6

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Excitatory Postsynaptic Potentials; Hippocampus; Indans; Long-Term Potentiation; Male; Phosphodiesterase Inhibitors; Piperidines; Pyrazoles; Pyrimidines; Rats; Rats, Wistar

2012